Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
Emerging Infectious Diseases · 2023
DOI: 10.3201/eid2907.230465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von J R Caldera und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dysentery, Bacillary, Shigella. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In Los Angeles, California, USA, persistent, refractory shigellosis was diagnosed in an immunocompetent man who has sex with men. Whole-genome sequencing augmented phenotypic antimicrobial susceptibility testing to comprehensively profile bacterial drug resistance and appropriately guide therapy and clear the infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Caldera, J. R., Yang, S., & Uslan, D. Z. (2023). Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022. Emerging Infectious Diseases. https://doi.org/10.3201/eid2907.230465
Vancouver
Caldera JR, Yang S, Uslan DZ. Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022. Emerging Infectious Diseases. 2023. doi:10.3201/eid2907.230465
BibTeX
@article{Caldera2023,
author = {Caldera, J R and Yang, Shangxin and Uslan, Daniel Z},
title = {Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022},
journal = {Emerging Infectious Diseases},
year = {2023},
doi = {10.3201/eid2907.230465}
}
EUVIMED